We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About ZD Medical Stock

Invest in or calculate the value of your shares in ZD Medical or other pre-IPO companies through EquityZen's platform.

Get Started

ZD Medical Stock (ZDMD)

ZD Medical is a medical device company that manufactures optical coherence tomography angiography devices.

About ZD Medical Stock

Founded

2015

Industries

Manufacturing, Health Care

ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both macular degeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.

ZD Medical Press Mentions

Stay in the know about the latest news on ZD Medical

ZD Medical Management

Leadership team at ZD Medical

Founder & Chairman of the Board

Lei (Eric) Tang

Board Member

William Hu

Locked Features

Join now and verify your accreditation status to gain access to:

  • ZD Medical Current Valuation
  • ZD Medical Stock Price
  • ZD Medical Management
  • Available deals in ZD Medical and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • ZD Medical Cap Table and Funding History by Share Class and Liquidity Preferences
    • ZD Medical Revenue and Financials
    • ZD Medical Highlights
    • ZD Medical Business Model
    • ZD Medical Risk Factors
  • ZD Medical Research Report from SACRA Research
Join Now

Trading ZD Medical Stock

How to invest in ZD Medical stock?

Accredited investors can buy pre-IPO stock in companies like ZD Medical through EquityZen funds. These investments are made available by existing ZD Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell ZD Medical stock?

Shareholders can sell their ZD Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."